In a pivotal 5-year follow-up of the FUGES-012 trial, patients who underwent indocyanine green (ICG) fluorescence-guided laparoscopic lymphadenectomy for gastric cancer exhibited significantly improved overall survival and disease-free survival compared to the non-ICG cohort. The ICG group also showed fewer recurrences, with a notable reduction in locoregional recurrences and an earlier recurrence peak in the non-ICG group. These findings advocate for ICG’s routine use in surgical settings.
Randomized Controlled Trial by Zhong Q, Wu D (…) Huang CM et 14 al. in BMC Med
© 2025. The Author(s).